Hsu, Yao-Chun
Chen, Chih-Cheng
Lee, Wei-Hsiang
Chang, Chi-Yang
Lee, Fu-Jen
Tseng, Cheng-Hao
Chen, Tzu-Haw
Ho, Hsiu J.
Lin, Jaw-Town
Wu, Chun-Ying
Funding for this research was provided by:
E-Da Cancer Hospital (EDCHP108006)
Yin Yen-Liang Foundation Development and Construction Plan (E107F-M01-0503)
Ministry of Science and Technology, Taiwan (MOST 108-2321-B-075-002)
Article History
Received: 23 July 2021
Accepted: 8 March 2022
First Online: 31 March 2022
Competing interests
: YCH has received lecture fees from Abbvie, Bristol-Myers Squibb and Gilead Sciences, served as an advisory committee member for Gilead Sciences, and received research support from Gilead Sciences. CYW and JTL has received research support from Gilead Sciences. CHT has received lecture fees from Abbvie, Bristol-Myers Squibb, Gilead Sciences, Roche, and Bayer. The remaining authors declare no competing interests.